Evidence map›Paper›PMID 30814564›Full record

ArticleScientific reports2019

Inactivation of Ppp1r15a minimises weight gain and insulin resistance during caloric excess in female mice.

Vruti Patel, Guillaume Bidault, Joseph E Chambers, Stefania Carobbio, Angharad J T Everden, Concepción Garcés, Lucy E Dalton, Fiona M Gribble, Antonio Vidal-Puig, Stefan J Marciniak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Vruti PatelCambridge Institute for Medical Research (CIMR), University of Cambridge Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.
Guillaume BidaultMetabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Joseph E ChambersCambridge Institute for Medical Research (CIMR), University of Cambridge Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.
Stefania CarobbioMetabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Angharad J T EverdenCambridge Institute for Medical Research (CIMR), University of Cambridge Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.
Concepción GarcésCambridge Institute for Medical Research (CIMR), University of Cambridge Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.
Lucy E DaltonCambridge Institute for Medical Research (CIMR), University of Cambridge Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.
Fiona M GribbleMetabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Antonio Vidal-PuigMetabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Stefan J MarciniakCambridge Institute for Medical Research (CIMR), University of Cambridge Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK. sjm20@cam.ac.uk.ORCID http://orcid.org/0000-0001-8472-7183
University of Cambridge · GBWellcome/MRC Institute of Metabolic Science · GBWellcome/MRC Cambridge Stem Cell Institute · GBWellcome Sanger Institute · GB

Funding

British Heart Foundation RG/12/13/29853British Heart Foundation RG/18/7/33636Medical Research Council G0400192Medical Research Council G0600717Medical Research Council G0601840Medical Research Council G0802051Medical Research Council G1002610Medical Research Council MC_UU_00014/2Medical Research Council MC_UU_00014/3Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/2Medical Research Council MC_UU_12012/3Medical Research Council MC_UU_12012/5Medical Research Council MR/R009120/1RCUK | Medical Research Council (MRC) G1002610Wellcome TrustWellcome Trust 093026Wellcome Trust 100140
6 · The paper itself

Abstract

Phosphorylation of the translation initiation factor eIF2α within the mediobasal hypothalamus is known to suppress food intake, but the role of the eIF2α phosphatases in regulating body weight is poorly understood. Mice deficient in active PPP1R15A, a stress-inducible eIF2α phosphatase, are healthy and more resistant to endoplasmic reticulum stress than wild type controls. We report that when female Ppp1r15a mutant mice are fed a high fat diet they gain less weight than wild type littermates owing to reduced food intake. This results in healthy leaner Ppp1r15a mutant animals with reduced hepatic steatosis and improved insulin sensitivity, albeit with a possible modest defect in insulin secretion. By contrast, no weight differences are observed between wild type and Ppp1r15a deficient mice fed a standard diet. We conclude that female mice lacking the C-terminal PP1-binding domain of PPP1R15A show reduced dietary intake and preserved glucose tolerance. Our data indicate that this results in reduced weight gain and protection from diet-induced obesity.

Indexed as

AnimalsDiet, High-FatEatingEndoplasmic Reticulum StressFemaleHumansHypothalamusInsulin ResistanceMiceMice, Inbred C57BLMice, KnockoutObesityPhosphorylationProtein Phosphatase 1Weight GainPpp1r15a protein, mouseProtein Phosphatase 1

Identifiers

PMID30814564
PMCPMC6393541
OpenAlexW2953238608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.